Marshall Wace, LLP Edgewise Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 54,617 shares of EWTX stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,617Holding current value
$1.06 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
129Shares Held
76.3MCall Options Held
14.7KPut Options Held
14.8K-
Orbimed Advisors LLC San Diego, CA15MShares$292 Million6.17% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$113 Million1.35% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$78.1 Million0.0% of portfolio
-
Viking Global Investors LP3.34MShares$64.9 Million0.23% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.23B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...